Cannabis CBD Marijuana
Click here for The Motley Idiot’s sources on Coronavirus and the market.
Cresco Labs (OTC:CRLBF) is one substantial step closer to opening its 2nd dispensary in downtown Chicago. The corporate announced Monday that it has got special use approval from the metropolis’s zoning board of appeals for its retailer within the River North district.
Acquiring the zoning permit approach the marijuana company has one final hurdle closing before the dispensary, that could well presumably honest endure the corporate’s Sunnyside tag title, could well perhaps be granted an grownup use dishing out group license — an inspection by the Illinois Division of Monetary and Authentic Regulation. If the dispensary passes the inspection and receives the license, it can well perhaps start for industry.
Image source: Cresco Labs
“Earning the appropriate to operate on this extremely coveted location is both a privilege and a well-known opportunity for Cresco,” the corporate mentioned within the press free up trumpeting the records. It didn’t hesitate to show that the upcoming Sunnyside location is terribly shut to the Pretty Mile, a busy Chicago searching district.
Sunnyside is the core of Chicago-primarily based fully mostly Cresco’s retail approach. The novel retailer will give it a full of six dispensaries in Illinois, simplest one of which is currently positioned in Chicago appropriate. The corporate additionally holds licenses to start one other four dispensaries, now not decrease than one of that could well presumably honest be positioned within the metropolis.
The timing of its Illinois assemble-out is auspicious; marijuana companies working within the say are reaping the advantages of a white-hot market since recreational pot legalization kicked in at the starting of this year.
Despite the appropriate data, Cresco’s inventory used to be dragged down by the endure market on Monday. Its shares fell by almost 19% on the day.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Cresco Labs Inc. The Motley Fool has a disclosure policy.